WS #16171
As risk appetite wanes, capital is rotating into defensive sectors, with healthcare emerging as a clear winner. Eli Lilly and Merck posted significant gains, outperforming the broader market as investors seek stability and predictable cash flows. This rotation underscores the market's current preference for quality and defensiveness over growth, driven by the prevailing geopolitical uncertainty and energy price shocks.
Defensive Rotation to Healthcare
As risk appetite wanes, capital is rotating into defensive sectors, with healthcare emerging as a clear winner. Eli Lilly and Merck posted significant gains, outperforming the broader market as investors seek stability and predictable cash flows. This rotation underscores the market's current preference for quality and defensiveness over growth, driven by the prevailing geopolitical uncertainty and energy price shocks.